Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
Gynäkologie in der Praxis
Erschienen in:

01.07.2021 | Originalien

Corpus luteum, vaskuläre Gesundheit und Präeklampsierisiko nach ART

verfasst von: Christian Trautmann, Prof. Dr. med. Frauke von Versen-Höynck, M.Sc.

Erschienen in: Gynäkologie in der Praxis | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die maternale perikonzeptionelle Gesundheit als auch die Gesundheit in der Frühschwangerschaft bestimmen das Risiko für die Entwicklung einer Präeklampsie mit. Hierbei kommt insbesondere im Rahmen der assistierten Reproduktion dem Corpus luteum und dessen vasoaktiven Sekretionsprodukten, wie dem Relaxin, eine Bedeutung zu. Dieser Artikel beschreibt mögliche Zusammenhänge zwischen der Corpus-luteum-Anzahl, der maternalen Gefäßgesundheit und dem Präeklampsierisiko. Dabei wird insbesondere auf das Fehlen des Corpus luteum bei artifiziellen Auftauzyklen eingegangen, die neben einer gestörten maternalen kardiovaskulären Adaptation in der Frühschwangerschaft mit einem erhöhten Präeklampsierisiko einhergehen können.
Vorheriger Artikel Physische, psychische und soziale Entwicklung der nach intrazytoplasmatischer Spermieninjektion geborenen Kinder – die Deutsche ICSI-Langzeitstudie
Nächster Artikel Hyperprolaktinämie bei der Frau
Literatur
1.
Burton GJ, Redman CW, Roberts JM et al (2019) Pre-eclampsia: pathophysiology and clinical implications. BMJ 366:l2381PubMedCrossRef
2.
Abalos E, Cuesta C, Grosso AL et al (2013) Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol 170(1):1–7PubMedCrossRef
3.
Ebisch IM, Thomas CM, Wetzels AM et al (2008) Review of the role of the plasminogen activator system and vascular endothelial growth factor in subfertility. Fertil Steril 90(6):2340–2350PubMedCrossRef
4.
Kampfer C, Saller S, Windschuttl S et al (2014) Pigment-Epithelium Derived Factor (PEDF) and the human ovary: a role in the generation of ROS in granulosa cells. Life Sci 97(2):129–136PubMedCrossRef
5.
Conrad KP (2011) Emerging role of relaxin in the maternal adaptations to normal pregnancy: implications for preeclampsia. Semin Nephrol 31(1):15–32PubMedPubMedCentralCrossRef
6.
Emmi AM, Skurnick J, Goldsmith LT et al (1991) Ovarian control of pituitary hormone secretion in early human pregnancy. J Clin Endocrinol Metab 72(6):1359–1369PubMedCrossRef
7.
Devoto L, Fuentes A, Kohen P et al (2009) The human corpus luteum: life cycle and function in natural cycles. Fertil Steril 92(3):1067–1079PubMedCrossRef
8.
9.
Schock H, Zeleniuch-Jacquotte A, Lundin E et al (2016) Hormone concentrations throughout uncomplicated pregnancies: a longitudinal study. BMC Pregnancy Childbirth 16(1):146PubMedPubMedCentralCrossRef
10.
Byers MJ, Zangl A, Phernetton TM et al (2005) Endothelial vasodilator production by ovine uterine and systemic arteries: ovarian steroid and pregnancy control of ERalpha and ERbeta levels. J Physiol 565(Pt 1):85–99PubMedPubMedCentralCrossRef
11.
Young SL, Savaris RF, Lessey BA et al (2017) Effect of randomized serum progesterone concentration on secretory endometrial histologic development and gene expression. Hum Reprod 32(9):1903–1914PubMedPubMedCentralCrossRef
12.
Simoncini T, Fu XD, Caruso A et al (2007) Drospirenone increases endothelial nitric oxide synthesis via a combined action on progesterone and mineralocorticoid receptors. Hum Reprod 22(8):2325–2334PubMedCrossRef
13.
Hermenegildo C, Oviedo PJ, García-Martínez MC et al (2005) Progestogens stimulate prostacyclin production by human endothelial cells. Hum Reprod 20(6):1554–1561PubMedCrossRef
14.
Conrad KP (2020) Evidence for corpus luteal and endometrial origins of adverse pregnancy outcomes in women conceiving with or without assisted reproduction. Obstet Gynecol Clin North Am 47(1):163–181PubMedPubMedCentralCrossRef
15.
16.
17.
Sherwood OD (2004) Relaxin’s physiological roles and other diverse actions. Endocr Rev 25(2):205–234PubMedCrossRef
18.
Wiegel RE, Danser AHJ, Steegers-Theunissen RP et al (2020) Determinants of maternal renin-angiotensin-aldosterone-system activation in early pregancy: insights from 2 cohorts. J Clin Endocrinol Metab 105(11):1–13CrossRef
19.
Itskovitz J, Sealey JE (1987) Ovarian prorenin-renin-angiotensin system. Obstet Gynecol Surv 42(9):545–551PubMedCrossRef
20.
Speth RC, Daubert DL, Grove KL (1999) Angiotensin II: a reproductive hormone too? Regul Pept 79(1):25–40PubMedCrossRef
21.
Yoshimura Y (1997) The ovarian renin-angiotensin system in reproductive physiology. Front Neuroendocrinol 18(3):247–291PubMedCrossRef
22.
Conrad KP, Baker VL (2013) Corpus luteal contribution to maternal pregnancy physiology and outcomes in assisted reproductive technologies. Am J Physiol Regul Integr Comp Physiol 304(2):R69–R72PubMedCrossRef
23.
Conrad KP, Graham GM, Chi YY et al (2019) Potential influence of the corpus luteum on circulating reproductive and volume regulatory hormones, angiogenic and immunoregulatory factors in pregnant women. Am J Physiol Endocrinol Metab 317(4):E677–E685PubMedPubMedCentralCrossRef
24.
von Versen-Höynck F, Hackl S, Selamet Tierney ES et al (2020) Maternal vascular health in pregnancy and postpartum after assisted reproduction. Hypertension 75(2):549–560CrossRef
25.
Khaw A, Kametas NA, Turan OM et al (2008) Maternal cardiac function and uterine artery Doppler at 11–14 weeks in the prediction of pre-eclampsia in nulliparous women. BJOG 115(3):369–376PubMedCrossRef
26.
De Paco C, Kametas N, Rencoret G et al (2008) Maternal cardiac output between 11 and 13 weeks of gestation in the prediction of preeclampsia and small for gestational age. Obstet Gynecol 111(2 Pt 1):292–300PubMedCrossRef
27.
Salas SP, Marshall G, Gutierrez BL et al (2006) Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction. Hypertension 47(2):203–208PubMedCrossRef
28.
Novak J, Danielson LA, Kerchner LJ et al (2001) Relaxin is essential for renal vasodilation during pregnancy in conscious rats. J Clin Invest 107(11):1469–1475PubMedPubMedCentralCrossRef
29.
Debrah DO, Novak J, Matthews JE et al (2006) Relaxin is essential for systemic vasodilation and increased global arterial compliance during early pregnancy in conscious rats. Endocrinology 147(11):5126–5131PubMedCrossRef
30.
Danielson LA, Sherwood OD, Conrad KP (1999) Relaxin is a potent renal vasodilator in conscious rats. J Clin Invest 103(4):525–533PubMedPubMedCentralCrossRef
31.
Chapman AB, Zamudio S, Woodmansee W et al (1997) Systemic and renal hemodynamic changes in the luteal phase of the menstrual cycle mimic early pregnancy. Am J Physiol 273(5 Pt 2):F777–F782PubMed
32.
Petersen JW, Liu J, Chi YY et al (2017) Comparison of multiple non-invasive methods of measuring cardiac output during pregnancy reveals marked heterogeneity in the magnitude of cardiac output change between women. Physiol Rep 5(8):e13223PubMedPubMedCentralCrossRef
33.
Jackson RA, Gibson KA, Wu YW et al (2004) Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol 103(3):551–563PubMedCrossRef
34.
Helmerhorst FM, Perquin DA, Donker D et al (2004) Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies. BMJ 328(7434):261PubMedPubMedCentralCrossRef
35.
Maman E, Lunenfeld E, Levy A et al (1998) Obstetric outcome of singleton pregnancies conceived by in vitro fertilization and ovulation induction compared with those conceived spontaneously. Fertil Steril 70(2):240–245PubMedCrossRef
36.
Pinborg A, Wennerholm UB, Romundstad LB et al (2013) Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta-analysis. Hum Reprod Update 19(2):87–104PubMedCrossRef
37.
Salha O, Sharma V, Dada T et al (1999) The influence of donated gametes on the incidence of hypertensive disorders of pregnancy. Hum Reprod 14(9):2268–2273PubMedCrossRef
38.
Sites CK, Wilson D, Barsky M et al (2017) Embryo cryopreservation and preeclampsia risk. Fertil Steril 108(5):784–790PubMedCrossRef
39.
Barsky M, Marie StP, Rahil T et al (2016) Are perinatal outcomes affected by blastocyst vitrification and warming? Am J Obstet Gynecol 215(5):603e1–603e5CrossRef
40.
Chen ZJ, Shi Y, Sun Y et al (2016) Fresh versus frozen embryos for infertility in the polycystic ovary syndrome. N Engl J Med 375(6):523–533PubMedCrossRef
41.
Sazonova A, Kallen K, Thurin-Kjellberg A et al (2012) Obstetric outcome in singletons after in vitro fertilization with cryopreserved/thawed embryos. Hum Reprod 27(5):1343–1350PubMedCrossRef
42.
Wei D, Liu JY, Sun Y et al (2019) Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial. Lancet 393(10178):1310–1318PubMedCrossRef
43.
Roque M, Haahr T, Geber S et al (2019) Fresh versus elective frozen embryo transfer in IVF/ICSI cycles: a systematic review and meta-analysis of reproductive outcomes. Hum Reprod Update 25(1):2–14PubMedCrossRef
44.
Saito K, Kuwahara A, Ishikawa T et al (2019) Endometrial preparation methods for frozen-thawed embryo transfer are associated with altered risks of hypertensive disorders of pregnancy, placenta accreta, and gestational diabetes mellitus. Hum Reprod 34(8):1567–1575PubMedCrossRef
45.
Ishihara O, Araki R, Kuwahara A et al (2014) Impact of frozen-thawed single-blastocyst transfer on maternal and neonatal outcome: an analysis of 277,042 single-embryo transfer cycles from 2008 to 2010 in Japan. Fertil Steril 101(1):128–133PubMedCrossRef
46.
Ginstrom Ernstad E, Wennerholm UB, Khatibi A et al (2019) Neonatal and maternal outcome after frozen embryo transfer: Increased risks in programmed cycles. Am J Obstet Gynecol 221(2):126e1–126e18CrossRef
47.
Lin J, Zhao J, Hao G et al (2020) Maternal and neonatal complications after natural vs. Hormone replacement therapy cycle regimen for frozen single Blastocyst transfer. Front Med 7:338CrossRef
48.
Opdahl S, Henningsen AA, Tiitinen A et al (2015) Risk of hypertensive disorders in pregnancies following assisted reproductive technology: a cohort study from the CoNARTaS group. Hum Reprod 30(7):1724–1731PubMedCrossRef
49.
Maheshwari A, Pandey S, Amalraj Raja E et al (2018) Is frozen embryo transfer better for mothers and babies? Can cumulative meta-analysis provide a definitive answer? Hum Reprod Update 24(1):35–58PubMedCrossRef
50.
Sha T, Yin X, Cheng W et al (2018) Pregnancy-related complications and perinatal outcomes resulting from transfer of cryopreserved versus fresh embryos in vitro fertilization: a meta-analysis. Fertil Steril 109(2):330–342.e9PubMedCrossRef
51.
Yang M, Lin L, Sha C et al (2020) Which is better for mothers and babies: fresh or frozen-thawed blastocyst transfer? BMC Pregnancy Childbirth 20(1):559PubMedPubMedCentralCrossRef
52.
Wang B, Zhang J, Zhu Q et al (2020) Effects of different cycle regimens for frozen embryo transfer on perinatal outcomes of singletons. Hum Reprod 35(7):1612–1622PubMedCrossRef
53.
Zong L, Liu P, Zhou L et al (2020) Increased risk of maternal and neonatal complications in hormone replacement therapy cycles in frozen embryo transfer. Reprod Biol Endocrinol 18(1):36PubMedPubMedCentralCrossRef
54.
Asserhøj LL, Spangmose AL, Aaris Henningsen AK et al (2021) Adverse obstetric and perinatal outcomes in 1,136 singleton pregnancies conceived after programmed frozen embryo transfer (FET) compared with natural cycle FET. Fertil Steril 115(4):947–956PubMedCrossRef
55.
Makhijani R, Bartels C, Godiwala P et al (2020) Maternal and perinatal outcomes in programmed versus natural vitrified-warmed blastocyst transfer cycles. Reprod Biomed Online 41(2):300–308PubMedCrossRef
56.
57.
58.
Zaat TR, Brink AJ, de Bruin JP et al (2021) Increased obstetric and neonatal risks in artificial cycles for frozen embryo transfers? Reprod Biomed Online 42(5):919–929PubMedCrossRef
59.
von Versen-Höynck F, Schaub AM, Chi YY et al (2019) Increased preeclampsia risk and reduced aortic compliance with in vitro fertilization cycles in the absence of a corpus luteum. Hypertension 73(3):640–649CrossRef
60.
Wang Z, Liu H, Song H et al (2020) Increased risk of pre-eclampsia after frozen-thawed embryo transfer in programming cycles. Front Med 7:104CrossRef
61.
Roelens C, Racca A, Mackens S et al (2020) Artificially prepared frozen embryo transfer cycles are associated with an increased risk of preeclampsia. Hum Reprod 35:108–109 (In: 36th Annual Meeting of ESHRE)
62.
Conrad KP, Petersen JW, Chi YY et al (2019) Maternal cardiovascular dysregulation during early pregnancy after in vitro fertilization cycles in the absence of a corpus luteum. Hypertension 74(3):705–715PubMedCrossRef
63.
von Versen-Höynck F, Narasimhan P, Selamet Tierney ES et al (2019) Absent or excessive corpus luteum number is associated with altered maternal vascular health in early pregnancy. Hypertension 73(3):680–690CrossRef
64.
von Versen-Höynck F, Strauch NK, Liu J et al (2019) Effect of mode of conception on maternal serum relaxin, creatinine, and sodium concentrations in an infertile population. Reprod Sci 26:412–419CrossRef
65.
Conrad KP, Lingis M, Sautina L et al (2020) Maternal endothelial function, circulating endothelial cells, and endothelial progenitor cells in pregnancies conceived with or without in vitro fertilization. Am J Physiol Regul Integr Comp Physiol 318(6):R1091–R1102PubMedPubMedCentralCrossRef
66.
Guan Y, Fan H, Styer AK et al (2016) A modified natural cycle results in higher live birth rate in vitrified-thawed embryo transfer for women with regular menstruation. Syst Biol Reprod Med 62(5):335–342PubMedCrossRef
Metadaten
Titel
Corpus luteum, vaskuläre Gesundheit und Präeklampsierisiko nach ART
verfasst von
Christian Trautmann
Prof. Dr. med. Frauke von Versen-Höynck, M.Sc.
Publikationsdatum
01.07.2021
Verlag
Springer Vienna
Erschienen in
Gynäkologie in der Praxis / Ausgabe 3/2021
Print ISSN: 3005-0758
Elektronische ISSN: 3005-0766
DOI
https://doi.org/10.1007/s41974-021-00191-x

Weitere Artikel der Ausgabe 3/2021

Teenagerschwangerschaften – ein weltweiter Überblick und die Situation in Österreich

  • Open Access
  • Mädchensprechstunde

Depression und Menopause

  • News-Screen Menopause

Editorial

  • Editorial

Hyperprolaktinämie bei der Frau

  • Open Access
  • Originalien

News-Screen Assistierte Reproduktion

  • News-Screen Assistierte Reproduktion

Weiblicher Haarverlust in der Postmenopause

  • Menopause heute und morgen